glp 1 triple agonist LY3437943, a novel glucagon, GIP, and GLP-1 receptor for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism The GLP-1 Revolution: How Next-Generation

Abstract This study has been initiated to investigate whether sunitinib (SUN) alters the expression of key genes engaged in mitochondrial transport and oxidation of long chain fatty acids (LCFA), and if so, whether these alterations should be viewed as a mechanism of SUN-induced cardiotoxicity, and to explore the molecular mechanisms whereby carnitine supplementation could attenuate SUN-induced cardiotoxicity

so, you can feel clear, restored, and supported with every visit

This review provides an analysis of GLP-1 RAs and their multi-agonist derivatives as therapeutic agents for MASLD, examining their biological mechanisms and clinical efficacy based on current evidence

A recent study has demonstrated that lactate-induced acidification of the microenvironment over a period of weeks induces a metabolic adaptation of the tumor cell population, promoting -oxidation as a metabolic strategy (the CorbetFeron Effect) 71